What's in Store for Cardinal Health (CAH) in Q4 Earnings?

Core Viewpoint - Cardinal Health, Inc. is set to report its fourth-quarter fiscal 2024 results on August 14, with expectations of earnings and revenue growth compared to the previous year [1][2]. Group 1: Earnings and Revenue Estimates - The consensus estimate for earnings in the fiscal fourth quarter is $1.72 per share, reflecting a 10.9% increase from the prior year's quarter [2]. - Revenue expectations are pegged at $58.72 billion, indicating a year-over-year growth of 9.9% [2]. Group 2: Segment Performance - Cardinal Health has restructured its reporting into new operating segments, including Pharmaceutical and Specialty Solutions, Global Medical Products and Distribution, and others [3]. - The Pharmaceutical segment reported revenues of approximately $50.7 billion in the third quarter of fiscal 2024, marking a 9% year-over-year increase, driven by branded pharmaceutical sales growth [3][4]. - The Medical segment's revenues grew by 4% year over year, supported by growth in at-Home Solutions and GMPD, with a profit of $20 million in the last reported quarter [4]. Group 3: Strategic Developments - In March 2024, Cardinal Health completed the acquisition of Specialty Networks, which is expected to enhance its offerings in urology, GI, and rheumatology, with plans for further investment in fiscal 2025 [5]. - The company is constructing a new distribution center in South Carolina, which is anticipated to improve supply chain efficiency and revenue generation [6]. Group 4: Earnings Prediction Model - The current Zacks model indicates that Cardinal Health does not conclusively predict an earnings beat for this reporting cycle, with an Earnings ESP of -0.17% and a Zacks Rank of 3 [7][8].